VFA
NVAX icon

Virtus Fund Advisers’s Novavax NVAX Stock Holding History

Virtus Fund Advisers’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$329K Buy
+13,260
New +$324K ﹤0.01% 438
2014
Q3 		– Sell
-893
Closed -$83K – 1667
2014
Q2 		$83K Buy
+893
New +$78.5K ﹤0.01% 1528

Other funds holding NVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtus Fund Advisers's NVAX Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Novavax (NVAX) in Q4 2017: 13,260 shares worth $329K. The stake represents ﹤0.01% of the portfolio and ranks #438 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in NVAX as recently as Q2 2014.

Virtus Fund Advisers first reported a position in NVAX in Q2 2014 and has held it in 2 quarters since. 134 funds tracked by Wall St. Rank hold NVAX as of Q4 2017.

  • Virtus Fund Advisers held 13,260 shares of Novavax worth $329K as of Q4 2017.
  • Novavax was a new Virtus Fund Advisers position in Q4 2017.
  • Novavax made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #438 holding.
  • Virtus Fund Advisers first reported a position in Novavax in Q2 2014 and has held it in 2 quarters since.
  • 134 funds tracked by Wall St. Rank held Novavax as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.